title: Onychomycosis. New therapies for an old disease.
abstract: The newer generation of antifungal agents such as itraconazole and terbinafine are more effective than the older therapies, griseofulvin and ketoconazole, in the treatment of dermatophyte pedal onychomycosis. Itraconazole can be administered as continuous dosing, 200 mg per day for 3 months, or in the form of pulse therapy, 200 mg twice a day for 1 week per month for 3 consecutive months. Terbinafine is given as continuous dosing, 250 mg per day for 3 months.
authors.affiliation: Department of Medicine, Sunnybrook Health Science Center, Toronto, Ontario.
authors.forename: A K
authors.initials: AK
authors.lastname: Gupta
authors.forename: R K
authors.initials: RK
authors.lastname: Scher
authors.forename: P
authors.initials: P
authors.lastname: De Doncker
authors.forename: D N
authors.initials: DN
authors.lastname: Sauder
authors.forename: N H
authors.initials: NH
authors.lastname: Shear
mesh_terms: D000368:Aged; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009281:Naphthalenes / Q000627:therapeutic use*; D014009:Onychomycosis / Q000188:drug therapy*; D000077291:Terbinafine; D014249:Trichophyton / Q000302:isolation & purification
chemical_list: D000935:Antifungal Agents; D009281:Naphthalenes; D017964:Itraconazole; D000077291:Terbinafine